Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review.
The company will continue to invest in clinical research and expand its team to grow partnerships with employers and health plans.
Kaia Health’s smartphone-based platform combines machine learning and the expertise of medical experts to create individualized treatments, including exercises, education and psychological interventions for patients. Since launching in 2016, Kaia Health has enrolled more than 400,000 users and raised $50 million.
More articles on digital transformation:
Texas Children’s is building a ‘startup culture’ with innovation, tech at the forefront
Four health tech companies expected to reach $1B soon
Optum Ventures leads funding for patient engagement platform: 4 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.